← Back to Clinical Trials
Recruiting NCT05142943

NCT05142943 Effectiveness of Virtual Bodily Illusion Intervention in Upper Limb Motor Function in People With Incomplete Spinal Cord Injury.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05142943
Status Recruiting
Phase
Sponsor University of Valencia
Condition Incomplete Spinal Cord Injury
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2021-11-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Visual illusionPhysical exerciseSham Visual illusion

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2021-11-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Previous studies have shown that the neuroplasticity of the residual corticospinal fibers, the motor cortex and the spinal neurons plays an important role in the spontaneous functional recovery of people with neurological or musculoskeletal pathology. However, it is also possible to stimulate the neuroplasticity mechanisms of these structures through techniques aimed at rehabilitating different deficits (for example, motor function or sensitivity). In general, intervention programs are usually carried out, in most cases, using low-cost strategies such as therapeutic physical exercise programs. The objective of this study is to analyze the effectiveness of visual illusion therapies in combination with conventional exercises on the symptoms and signs related to incomplete spinal cord injury that affects the upper limb. The study will include the realization of three measurements that will be carried out one day before starting the program, one day after finishing it, and one month later (follow-up). The clinical assessment will be composed of the study of the following variables: Motor function and motor skills, Upper limb isometric force, Muscle activation, Muscle tone, Quality of life, Functionality. All interventions will last eight weeks and will be planned according to the availability of volunteers. In each session, it will be recorded if any type of adverse effect occurs. There will be four types of interventions: i. Visual Illusion (IV) and therapeutic exercise program (PE), ii.placebo and PE, iii. IV, iv. IV placebo.

Eligibility Criteria

Inclusion Criteria: * Incomplete cervical spinal cord injury (AIS C, D or E). * Ability to understand instructions (Mini-Mental State Examination\> 23 points) Exclusion Criteria: * Traumatic pathology in upper limbs. * Other alterations of the central nervous system or peripheral * Alterations in the vestibular system. * Concomitant diseases.

Frequently Asked Questions

Who can join the NCT05142943 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Incomplete Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05142943 currently recruiting?

Yes, NCT05142943 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Valencia to inquire about joining.

Where is the NCT05142943 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT05142943 clinical trial?

NCT05142943 is sponsored by University of Valencia. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology